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Prion protein is considered to have an infectious ability by itself. However, in order to explain the main
features of prion diseases, additional cofactors would be required. Sanghera et al. (in this issue of Chemistry
and Biology) have found evidence that a ganglioside, GM1, is a ligand for the C-terminal region of prion
protein.The ‘‘protein only’’ hypothesis attributes
infectious ability to a single protein and
has been harshly debated for decades
(Soto and Castilla, 2004). Although there
was compelling evidence that supported
this idea, studies based on cell-free
conversion (Kocisko et al., 1994), protein
misfolding cyclic amplification (PMCA)
(Castilla et al., 2005), and generation of
synthetic (Legname et al., 2004) and re-
combinant prions (Wang et al., 2010)
were required to confirm the hypothesis.
While the key protagonist role of prion
protein (PrP) has not been challenged,
the failure to explain the principal features
of prion diseases has motivated the
search for additional cofactors. First,
studies to determine the minimal compo-
nents for in vitro prion replication showed
how enriched membrane subsets and
detergent-solubilized membrane frac-
tions were enough to support prion repli-
cation in vitro (Nishina et al., 2004). Later,
studies based on PMCA successfully
replicated prions using only cellular PrP
(PrPC), co-purified lipid molecules, and
a synthetic polyanion (Deleault et al.,
2005). In a similar way, Wang et al.
(2010), using mouse recombinant PrP,
lipids, and RNA as cofactors for the
PMCA substrate, obtained the first highly
infectious recombinant prions. At that
time, it seemed that lipids were an inevi-
table requirement for in vitro prion replica-
tion. However, Kim et al. (2010), using a
PMCAvariation, showed that prions caus-
ing transmissible spongiform encepha-
lopathy in wild-type hamsters could be
generated solely from highly-purified,
bacterially-expressed recombinant ham-
ster PrP without any mammalian or syn-
thetic cofactors (other than buffer, salts,and detergent). Despite these studies
demonstrating that no other cofactors
were necessary for in vitro prion replica-
tion, the fact that recovered infectivity was
low, led some researchers to consider
lipids not just as helpers for prion replica-
tion but as triggers for in vivo prion propa-
gation. Moreover, none of the previous
studies, with the exception of the stan-
dard PMCA (Castilla et al., 2005), were
able to maintain the strain phenomenon
(different conformations of the PrP show-
ing distinct biological and physicochem-
ical properties), thus after every in vitro
process a newprion strainwas generated.
In this in vitro situation and focusing
on lipids as PrP ligands, it could be sug-
gested that they might act by clustering
the PrPC and PrPSc (misfolded form
of PrPC) molecules, thus propitiating pro-
tein-protein interaction. In a similar way
but in an in vivo environment, Sanghera
et al. (2011, in this issue of Chemistry &
Biology) propose that GM1 ganglioside
is a ligand for the C-terminal region of
PrP. The authors show that subtle
structural changes in PrP occur as a
consequence of GM1 binding. In partic-
ular, GM1 lipid chains appear to have a
role in modulating PrP structure. In con-
trast, PrP does not bind 1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine
(zwitterionic) bilayers, and it does bind
2-oleoyl-1-palmitoyl-sn-glycero-3-phos-
pho-rac-[1-glycerol] (negatively charged)
bilayers, but then extensive protein aggre-
gation on the membrane surface occurs.
Sanghera et al. (2011) have shown how
GM1, a lipid very abundant in raft-like
domains, binds a specific region of PrP.
Two aspects of observed PrP binding
to the cell membranes deserve someChemistry & Biology 18, November 23, 2011 ªcommentary. One is the apparent in-
volvement of both electrostatic and
hydrophobic forces in GM1-PrP interac-
tion, which is common with many other
proteins operating at the lipid-water
interface in membranes. Even more
interesting is the fact that PrP is mem-
brane-anchored through a glycosylphos-
phatidylinositol (GPI), covalently linked to
the protein C terminus. The authors
show that the GM1 binding site is also
close to the C terminus, an area sug-
gested to modulate PrP misfolding.
Thus, the immediate question is raised
about the influence of the GPI moiety on
ganglioside binding in vivo, an obvious
object for further investigation.
Although the experiments have been
performed using recombinant PrP, these
studies should be the prelude for others
in which PrPSc or rec-PrPSc [respec-
tively infectious and misfolded forms of
PrP(23-231)] would be involved as a
further approach toward understanding
prion propagation in vivo. The fact
that the authors have observed a direct
association between PrP and the GM1
oligosaccharide moiety suggests that
lipids might have a role for propagating
prions through PrPC-PrPSc conversion
within raft domains. Because this associ-
ation causes some structural changes
in PrP, and assuming that identical
changes take place when PrP is GPI-
anchored to a membrane, a trigger role
for sporadic cases of prion diseases
might be attributed to the lipid. In order
to support this idea, it would be crucial
to know how the interaction of GM1 and
PrPSc occurs and how such interaction
would mediate in the entire propagation
process.2011 Elsevier Ltd All rights reserved 1345
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Figure 1. PET-Blot Analysis Shows a Characteristic Pattern of PrPSc Deposition
PrPSc depositions are very specific for each prion strain and might signify a differential PrPSc interaction
and/or replication depending on the amount of PrPC ready to be converted. The figure shows a plausible
model where this convertibilitymight be depending on theGM1 binding that would slightly modify the PrPC
structure, making it more suitable for conversion. The differences in GM1 density might be determinant
and would explain the different PrPSc deposition patterns observed in PET-blot analysis.
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PreviewsGangliosides are abundant in the brain
and are found in virtually all mammalian
cell membranes, yet their specific role
remains largely unknown. A defect in
ganglioside synthesis has been related
to a form of familiar epilepsy (Simpson
et al., 2004). Gangliosides are effective
targets for a number of bacteria and
bacterial toxins, while also providing
resistance to phospholipase attack (Ur-
bina et al., 2011). Now GM1 has been
found to bind a specific region of PrP likely
involved in disease susceptibility. Given
the high concentrations of gangliosides
in neurons and their localization in specific
raft domains, the authors suggest that the
association of PrP with GM1 can play
a role in modulating disease suscepti-
bility. This study is especially relevant
due to our lack of knowledge on how
the transmission barriers are controlled
in vivo and provides new insights for its
understanding. In the same direction, the1346 Chemistry & Biology 18, November 23,specific lipid-protein interaction might be
used to explain another important feature
of prion diseases related to prion strains,
namely the erratic behavior of different
prion strains when infecting different
culture cells. It could also help to under-
stand why prion strains show specific
PrPSc accumulation patterns in different
regions of the brain. Prion strains could
have specific affinity for certain neurons
depending on the different lipid composi-
tion in their membranes (Figure 1).
Although the first thought that comes
to mind when PrP is mentioned is prion
diseases, PrP likely has a specific physio-
logical function, unfortunately as yet
unknown. Despite this lack of under-
standing,PrPpresence in raft-likedomains
would have important implications. Thus,
the authors propose that lipid-PrP interac-
tionsmight be involved in cell signaling and
cell recognition, processes at the cell
membrane in which protein segregation2011 ª2011 Elsevier Ltd All rights reservedinto specific domains and lipid-protein
interactions could be essential.
The very interesting observation of
GM1-PrP interaction in vitro demands
an investigation in the in vivo situation.
Equally important is the exploration of
GM1-PrPSc interaction, i.e., whether or
not the interaction is protein confor-
mation dependent. Also, the nature of
the ganglioside may be important. Are
other gangliosides binding PrP with
similar affinities? Prions are known to
replicate easily in the lymphoreticular
tissue; what are the gangliosides found
in that tissue, and what is their interaction
with PrP? A screening of gangliosides
appears as a prime line of research.
Finally, the pathogenesis of prion dis-
eases remains largely unknown. PrPSc
does not appear to be toxic in itself, thus
the process leading to neuronal death
remains an enigma. A putative binding
of PrPSc to ganglioside(s) would open a
new avenue for research in this area.REFERENCES
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